Rapid PCR / NAAT Analyzer

The Regional Health Contracting Office- Pacific (JBLM-HCB) is issuing this sources sought synopsis as a means of conducting market research to identify potential sources having an interest and industry technologies available to support/provide an equipment rental and supply contract for a Rapid (~ 20 minute) CLIA waived Polymerase Chain Reaction (PCR)/Nucleic Acid Amplification Test (NAAT) analyzer(s) for rapid identification of Influenza A & B, SARS-CoV-2, Respiratory Syncytial Virus (RSV), and Streptococcus Group A. to support the Department of Pathology at Madigan Army Medical Center (MAMC), Joint Base Lewis-McChord, WA 98431.

THIS IS A REQUEST FOR INFORMATION (RFI) ONLY.  This RFI is issued solely for information and planning purposes – it does not constitute a Request for Quote (RFQ) or signify an RFQ will ultimately be issued.  This request for information does not commit the Government to a contract for any supply or service whatsoever.  Further, Joint Base Lewis McChord-Health Contracting Branch (JBLM-HCB) is not at this time seeking quotes.  Respondees are advised that the U.S. Government will not pay for any information or administrative costs incurred in response to this RFI; all costs associated with responding to this RFI will be solely at the interested party’s expense.  Not responding to this RFI does not preclude participation in any future RFQ, if any is issued. It is the responsibility of the potential offerors to monitor this site for additional information pertaining to this requirement.

DISCLAIMER

THIS SOURCES SOUGHT IS FOR INFORMATIONAL PURPOSES ONLY. THIS IS NOT A REQUEST FOR PROPOSAL (RFP) TO BE SUBMITTED. IT DOES NOT CONSTITUTE A SOLICITATION AND SHALL NOT BE CONSTRUED AS A COMMITMENT BY THE GOVERNMENT. RESPONSES IN ANY FORM ARE NOT OFFERS AND THE GOVERNMENT IS UNDER NO OBLIGATION TO AWARD A CONTRACT AS A RESULT OF THIS ANNOUNCEMENT. NO FUNDS ARE AVAILABLE TO PAY FOR PREPARATION OF RESPONSES TO THIS ANNOUNCEMENT. ANY INFORMATION SUBMITTED BY RESPONDENTS TO THIS TECHNICAL DESCRIPTION IS STRICTLY VOLUNTARY AND BECOMES PROPERTY OF THE GOVERNMENT AND WILL NOT BE RETURNED.

PROGRAM BACKGROUND

PERIOD OF PERFORMANCE: The period of performance is a one year base period and two option years if exercised; 1 October 2021 through 30 September 2022; 1 October 2022 through 30 September 2023; 1 October 2023 through 30 September 2024.

Place of Performance:

Madigan Army Medical Center

Department of Pathology

Tacoma, WA 98431

REQUIRED CAPABILITIES

See attachments:

1. SOW Rapid PCR
2. Salient Characteristics Rapid PCR
    
   
   ELIGIBILITY
    
   The applicable NAICS code for this requirement is 339112 (Surgical and Medical Instrument Manufacturing) with a Small Business Size Standard of 1,000 Employees. The Product Service Code (PSC) is 6550 (In Vitro Diagnostic Substances, Reagents, Test Kits and Sets).
    
   SUBMISSION DETAILS
    
   Interested businesses should submit a brief capabilities statement package (no more than ten 8.5 X 11 inch pages, font no smaller than 10 point) demonstrating ability to provide the products/systems listed in this Technical Description. Documentation should be in bullet format. No phone or email solicitations with regards to the status of the RFP will be accepted prior to its release.
    
   Your response to this Sources Sought, including any capabilities statement, shall be electronically submitted to the Contract Specialist, Alfonso Nolasco, in either Microsoft Word or Portable Document Format (PDF), via email alfonso.nolasco.civ@mail.mil  no later than 12:00 p.m. (Pacific) on Fri, 6 Aug 2021 and reference this synopsis number in subject line of e-mail and on all enclosed documents. Information and materials submitted in response to this request WILL NOT be returned. DO NOT SUBMIT CLASSIFIED MATERIAL.
    
   If your organization has the potential capacity to provide the required products/systems, please provide the following information: 1) Organization name, address, primary points of contact (POCs) and their email address, FAX, Web site address, telephone number, and type of ownership for the organization; and 2) Tailored capability statements addressing the requirements of this notice, with appropriate documentation supporting claims of organizational and staff capability 3) GSA contract information if applicable.
    
   All data received in response to this Sources Sought that is marked or designated as corporate or proprietary will be fully protected from any release outside the Government.